http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201201530-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201201530-A1
titleOfInvention COMBINATION OF 4- {3- [CYC-HEXAGYDROCYCLOPENT [C] PYRROL-2- (1H) -IL] PROPOXY} BENZAMIDE AND NMDA-RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS, WHICH HAVE A VOLUME OF THE HYDROGECTOR AND THE ANTAGONIST
abstract A combination of 4- {3- [cis-hexahydrocyclopenta [c] pyrrole-2 (1H) -yl] propoxy} benzamide of formula (I) or a pharmaceutically acceptable acid or base addition salt thereof and a glutamate NMDA receptor antagonist thereof. Medicines
priorityDate 2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10100

Total number of triples: 22.